SalubrisBio has reported Phase 1b/2 results for its investigational antibody-drug [...]

Ariadne Bio has launched with funding from The Michael J [...]

Resolution Therapeutics has treated the final patient in its Phase [...]

ENA Respiratory has begun dosing participants in Part B of [...]

AstraZeneca is evaluating its oral IRAK4 inhibitor AZD6793 in a [...]

Early Phase 1b data show five objective responses among six [...]

Sagimet Biosciences is preparing to begin screening patients for its [...]

Lumen Bioscience has received up to $7m in US government [...]

Grifols has completed patient follow-up in its Phase 3 SPARTA [...]

Medicus Pharma has received FDA clearance to begin a Phase [...]